CVS Group complete transition from AIM to the Main Market of the LSE
January 2026
Established in 1999, CVS Group is a leading provider of veterinary services and has been listed on AIM since October 2007. The Group operates across the UK and Australia, with a clear focus on delivering high-quality clinical care to clients and their animals, supported by dedicated and highly skilled clinical teams and colleagues.
CVS Group now operates approximately 470 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. In addition to its core Veterinary Practices division, the Group operates diagnostic Laboratories serving both CVS and third-party customers, as well as an online retail business – Animed Direct.
The Group employs around 8,900 people, including approximately 2,400 veterinary surgeons and 3,300 veterinary nurses
Admission to the Main Market of the LSE
On 29th January 2025, the admission to the Equity Shares (Commercial Companies) category of the Official List and to trading on the Main Market of the London Stock Exchange commenced.
The Perivan shareholder communications team was delighted to work with Berenberg who acted as Sponsor and Joint Corporate Broker to CVS on the 94-page Prospectus.
For further information, click here.
Perivan is the market-leading provider of New Issue and IPO admission document production, having maintained its leadership position for six consecutive years.